Delisting riskPopularity #3,921
Cosmos Health (COSM)
Distributes health products through Greek pharmacies while manufacturing and marketing proprietary healthcare brands.
$0.3852
vs last close+0.03 (+8.75%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 3.87% | 2.11M shares | |
|---|---|---|---|
| 21 holders · as of Jun 30, 2026 | |||
| Insiders | 32.09% | 17.47M shares | |
| 7 holders · as of Jul 31, 2026 | |||
| Other | 64.04% | 34.85M shares | |
| remainder | |||
54.43M company shares as of Aug 27, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
21 holders · 2.11M shares · 4 new positions · 10 increased · 5 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| UBS Group AG | 594.5K | 1.09% | +581.7K | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | 333.8K | 0.61% | +238.1K | Aug 13, 2026 |
| Jane Street Group, LLC | 289.3K | 0.53% | +289.3Knew | Aug 14, 2026 |
| Geode Capital Management, LLC | 282.1K | 0.52% | −36.0K | Aug 12, 2026 |
| BlackRock, Inc. | 267.8K | 0.49% | 0 | Aug 7, 2026 |
| Vanguard Capital Management LLC | 174.0K | 0.32% | +34.0K | Aug 13, 2026 |
| Northern Trust Corp | 53.9K | 0.10% | +33.3K | Aug 13, 2026 |
| State Street Corp | 45.2K | 0.08% | 0 | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Grigorios Siokas | 22.90% | 6.87M | 13D | May 27, 2025 |
| Siokas Grigorios | 17.00% | 4.20M | 13D | Jan 29, 2025 |
| Bovopoulos Andreas | 10.00% | 3.73M | 13G | Mar 10, 2026 |
| Andreas D Bovopoulos | 7.00% | 1.88M | 13G | Mar 6, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 30, 2026 | Grigorios Siokasdirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 349,825 | $0.2001 | 14,597,917 |
| Jul 29, 2026 | Grigorios Siokasdirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 766,284 | $0.1827 | 14,248,092 |
| Jun 16, 2026 | Georgios Terzisofficer: Chief Financial Officer | Purchase | 168,135 | $0.2498 | 2,235,398 |
| Jun 10, 2026 | Grigorios Siokasdirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 701,447 | $0.2281 | 13,263,361 |
| Jun 11, 2026 | Grigorios Siokasdirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 218,447 | $0.2060 | 13,481,808 |
| Feb 12, 2026 | Grigorios Siokasdirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 388,532 | $0.3732 | 8,861,914 |
| Feb 11, 2026 | Grigorios Siokasdirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 291,262 | $0.4120 | 8,473,382 |
| Jan 23, 2026 | Grigorios Siokasdirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 90,325 | $0.4982 | 8,182,120 |
| Jan 20, 2026 | Grigorios Siokasdirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 353,321 | $0.4953 | 8,091,795 |
| Jan 14, 2026 | Grigorios Siokasdirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 493,495 | $0.4458 | 7,738,474 |
House and Senate disclosures
Not reported.